Methylphenidate-induced rabbit syndrome [4]

Annals of Pharmacotherapy

Volumn 40, Issue 11, 2006, Pages 2076-

  Mendhekar, Dattatreya N ^a   Duggal, Harpreet S ^b  

^a Neuropsychiatry and Headache Clinic   (India)

^b Herrick Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; CHOREOATHETOSIS; CLINICAL ARTICLE; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT SYNDROME; SCHOOL CHILD; TREATMENT OUTCOME;

CHILD; DYSKINESIA, DRUG-INDUCED; HUMANS; MALE; METHYLPHENIDATE; MOVEMENT DISORDERS;

EID: 33751018589     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H086     Document Type: Letter

References (8)

1. Casey DE. Rabbit syndrome. In: Joseph AB, Young RR, eds. Movement disorders in neurology and neuropsychiatry. London: Blackwell Scientific Publications, 1992:139-42.
2. Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Arlington, VA: American Psychiatric Publishing, 2000.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
4. Extein I. Methylphenidate-induced choreoathetosis. Am J Psychiatry 1978;135:252-3.
5. Schwartz M, Hocherman S. Antipsychotic-induced rabbit syndrome: epidemiology, management and pathophysiology. CNS Drugs 2004;18:213-20.
6. Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder. Arch Pediatr Adolesc Med 1994;148:859-6l.
7. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention deficit/hyperactivity disorder. Pediatrics 2001;108:1033-44.
8. Parvin MM, Swartz CM. Dystonic rabbit syndrome from citalopram. Clin Neuropharmacol 2005;28:289-91.